Reuters logo
BRIEF-GlaxoSmithKline seeks U.S. approval for melanoma drug combination
July 9, 2013 / 6:06 AM / 4 years ago

BRIEF-GlaxoSmithKline seeks U.S. approval for melanoma drug combination

LONDON, July 9 (Reuters) - GlaxoSmithKline Plc : * GSK announces U.S. submission for dabrafenib/trametinib combination in

metastatic melanoma

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below